Search results for "PARKINSON'S"

showing 10 items of 232 documents

Clinical effects of different montages of Transcranial Direct Current Stimulation (tDCS) in patients with Parkinson’s Disease

2016

Background: Parkinson’s disease (PD) is characterized by motor deficits which may not completely respond to the dopaminergic therapy, thus posing a therapeutic challenge. Non-invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) have shown promising results as possible alternative of treatment in different neurological disorders including PD. The therapeutic effect of tDCS, which may increase (anodal currents) or decrease (cathodal currents) the cortical excitability level, likely relies on modulation of cortico-subcortical interactions and abnormal patterns of cortical activation. Objective: To investigate safety and therapeutic potential of different…

Settore MED/26 - NeurologiaParkinson's disease tDCS
researchProduct

Parkinson's Disease and Cancer

2009

Epidemiological evidence suggests a reduced incidence of many common types of cancers in individuals with Parkinson's disease (PD). Parkinson's disease and cancer are two diseases that result from an excessive signaling by one of two forces driving cells to opposite directions. PD results from the excessive death of dopaminergic neurons in the substantia nigra pars compacta (SNc) in the brain, while uncontrolled growth is the key property of cancer. Parkinson's disease is a complex disorder, probably due in most of the cases to the interaction of environment and genes. Many genes responsible for familial forms of PD are supposed to have a supportive role in regulating or maintaining the cel…

Settore MED/26 - NeurologiaSettore BIO/06 - Anatomia Comparata E CitologiaParkinson's disease • cancer • epidemiology • genetics • risk factors
researchProduct

Sleep and sleepiness in Parkinson’s disease: result of a “spontaneous” observational study on rotigotine

2010

Settore MED/26 - Neurologiarotigotine sleep parkinson's disease
researchProduct

Sleep quality in caregivers of Parkinson’s disease and Alzheimer’s disease patients and its relationship to quality of life

2010

Settore MED/26 - Neurologiasleep quity caregivers Parkinson's disease alzheimer disease
researchProduct

Mitochondrial DNA TRNACYS mutation in a family with frontotemporal dementia and Parkinson’s disease

2010

TRNACYS mutation frontotemporal dementia Parkinson's diseaseSettore MED/26 - Neurologia
researchProduct

D2R striatopallidal neurons inhibit both locomotor and drug reward processes.

2009

The specific functions of dopamine D(2) receptor-positive (D(2)R) striatopallidal neurons remain poorly understood. Using a genetic mouse model, we found that ablation of D(2)R neurons in the entire striatum induced hyperlocomotion, whereas ablation in the ventral striatum increased amphetamine conditioned place preference. Thus D(2)R striatopallidal neurons limit both locomotion and, unexpectedly, drug reinforcement.

Time FactorsstriatumParkinson's diseaseStriatumNeurons -- drug effectsEnkephalins -- metabolism10263 Institute of Experimental ImmunologyMiceDopamine Uptake InhibitorsTyrosine 3-Monooxygenase -- geneticsCorpus Striatum -- cytologyDiphtheria ToxinGlutamate Decarboxylase -- metabolismstriatum; indirect opathway; A2A receptors; D2 receptors; locomotion; amphetamine addiction; Parkinson's diseaseNeuronsamphetamine addictionGlutamate DecarboxylaseGeneral NeuroscienceAmphetamine -- pharmacologyNeurodegeneration2800 General NeuroscienceEnkephalinsSciences bio-médicales et agricoleslocomotionmedicine.anatomical_structureA2A receptorsIntercellular Signaling Peptides and ProteinsReceptors Dopamine D2 -- metabolismPsychologyLocomotionmedicine.drugHeparin-binding EGF-like Growth FactorProtein BindingGlobus Pallidus -- cytologyReceptors Dopamine D2 -- deficiencyReinforcement ScheduleTyrosine 3-MonooxygenaseGlutamate Decarboxylase -- geneticsLocomotion -- geneticsIntercellular Signaling Peptides and Proteins -- genetics610 Medicine & healthMice TransgenicNerve Tissue ProteinsDiphtheria Toxin -- pharmacologyGlobus PallidusNeurons -- physiologyLocomotion -- drug effectsRewardDopamineDopamine receptor D2medicineNerve Tissue Proteins -- metabolismAnimalsGene Expression Regulation -- geneticsAmphetamineD2 receptorsReceptors Adenosine A2Receptors Dopamine D2indirect opathwayVentral striatumReceptors Adenosine A2 -- geneticsDopamine Uptake Inhibitors -- pharmacologymedicine.diseaseConditioned place preferenceCorpus StriatumMice Inbred C57BLGene Expression Regulation -- drug effectsAmphetaminenervous systemGene Expression RegulationProtein Binding -- drug effectsTyrosine 3-Monooxygenase -- metabolism570 Life sciences; biologyAutoradiographyConditioning OperantNeuronConditioning Operant -- physiologyNeuroscienceEnkephalins -- geneticsNature neuroscience
researchProduct

Discovering the Discriminating Power in Patient Test Features Using Visual Analytics: A Case Study in Parkinson’s Disease

2016

Part 11: New Methods and Tools for Big Data Wokshop (MT4BD); International audience; This paper presents a novel methodology for selecting the most representative features for identifying the presence of the Parkinson’s Disease (PD). The proposed methodology is based on interactive visual analytic based on multi-objective optimisation. The implemented tool processes and visualises the information extracted via performing a typical line-tracking test using a tablet device. Such output information includes several modalities, such as position, velocity, dynamics, etc. Preliminary results depict that the implemented visual analytics technique has a very high potential in discriminating the PD …

Visual analytics[ INFO ] Computer Science [cs]Parkinson's diseaseComputer science02 engineering and technology[INFO] Computer Science [cs]Machine learningcomputer.software_genre03 medical and health sciences0302 clinical medicineMulti-objective optimisation0202 electrical engineering electronic engineering information engineeringmedicineFeature (machine learning)[INFO]Computer Science [cs]In patient[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Modalitiesbusiness.industryVisual analyticsFeature discrimination powermedicine.diseaseTest (assessment)Power (physics)Identification (information)[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Parkinson’s disease[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]020201 artificial intelligence & image processingData miningArtificial intelligencebusinesscomputer030217 neurology & neurosurgery
researchProduct

Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson’s Disease

2021

Parkinson’s disease (PD) is the second most frequent neurodegenerative disease. It is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of large aggregates in the survival neurons called Lewy bodies, which mainly contain α-synuclein (α-syn). The cause of cell death is not known but could be due to mitochondrial dysfunction, protein homeostasis failure, and alterations in the secretory/endolysosomal/autophagic pathways. Survival nigral neurons overexpress the small GTPase Rab1. This protein is considered a housekeeping Rab that is necessary to support the secretory pathway, the maintenance of the Golgi complex structure, and the regulation of macroau…

autophagyParkinson's diseaseQH301-705.5Substantia nigraReviewBiologyCatalysisInorganic Chemistryα-synucleinmedicineAnimalsHumansSmall GTPaseBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopySecretory pathwayRab1GTPasesOrganic ChemistryNeurodegenerationDopaminergicRAB1Parkinson DiseaseLRRK2General Medicinemedicine.diseaseLRRK2Computer Science Applicationssecretory pathwayrab1 GTP-Binding ProteinsChemistrynervous systemParkinson’s diseaseNeuroscienceGolgi fragmentationInternational Journal of Molecular Sciences
researchProduct

Comparison of Shod and Unshod Gait in Patients With Parkinson's Disease With Subthalamic and Nigral Stimulation

2022

Background: The Parkinsonian [i.e., Parkinson's disease (PD)] gait disorder represents a therapeutical challenge with residual symptoms despite the use of deep brain stimulation of the subthalamic nucleus (STN DBS) and medical and rehabilitative strategies. The aim of this study was to assess the effect of different DBS modes as combined stimulation of the STN and substantia nigra (STN+SN DBS) and environmental rehabilitative factors as footwear on gait kinematics.Methods: This single-center, randomized, double-blind, crossover clinical trial assessed shod and unshod gait in patients with PD with medication in different DBS conditions (i.e., STIM OFF, STN DBS, and STN+SN DBS) during differe…

barefootsubthalamic nucleusParkinson's diseaseHuman NeuroscienceNeurosciences. Biological psychiatry. NeuropsychiatryBrief Research Reportshoesgaitbehavioral disciplines and activitiesnervous system diseasesdeep brain stimulationBehavioral NeurosciencePsychiatry and Mental healthNeuropsychology and Physiological Psychologysurgical procedures operativeNeurologynervous systemsubstantia nigratherapeuticsBiological PsychiatryRC321-571Frontiers in Human Neuroscience
researchProduct

Formation of covalent di-tyrosine dimers in recombinant α-synuclein

2015

Parkinson's disease is associated with fibril deposition in the diseased brain. Misfolding events of the intrinsically disordered synaptic protein α-synuclein are suggested to lead to the formation of transient oligomeric and cytotoxic species. The etiology of Parkinson's disease is further associated with mitochondrial dysfunction and formation of reactive oxygen species. Oxidative stress causes chemical modification of native α-synuclein, plausibly further influencing misfolding events. Here, we present evidence for the spontaneous formation of covalent di-tyrosine α-synuclein dimers in standard recombinant protein preparations, induced without extrinsic oxidative or nitrative agents. The…

chemistry.chemical_classificationReactive oxygen speciesParkinson's diseasealphasynucleinamyloids di-tyrosine dimers EOM Parkinson’s disease SAXSSAXSOxidative phosphorylationFibrilmedicine.disease_causeIndustrial and Manufacturing Engineeringchemistry.chemical_compoundα-synucleinMonomerchemistryBiochemistryCovalent bondmedicinedi-tyrosine dimersamyloidsTyrosineProtein secondary structureEOMOxidative stressResearch PaperIntrinsically Disordered Proteins
researchProduct